Ross Fulton

Ross Fulton currently serves as the VP of Immunology and Vaccine Development at Akagera Medicines, Inc., following a role as Senior Director of Immunology. Previous positions include Principal Scientist at HiFiBiO Therapeutics, where Ross led an antibody discovery program, and Merrimack, directly overseeing pre-clinical immunology research on murine surrogate mAbs. Ross's earlier experience encompasses leading in vivo research at Biothera Pharmaceuticals, along with a postdoctoral associate position at the University of Minnesota focused on T cell responses, resulting in a publication in Nature Immunology. Ross holds a Ph.D. in Immunology from the University of Iowa and a BA in Biology and Mathematics from St. Olaf College.